Breast Cancer

Featured

News
Targeted BRCA or multiple gene screening is cost-effective for preventing breast and ovarian cancer, according to a recent study.
Quiz
True or False: Circulating tumor cell count is a reliable biomarker for choosing between chemotherapy or endocrine…
News
Circulating tumor cell count is a reliable biomarker for choosing between chemotherapy or endocrine therapy for…
News
Results from a survey show that most physicians are de-escalating bone modifying agents in patients with bone…
Quiz
True or False: Population-wide genomic screening for hereditary breast and ovarian cancer is cost-effective among…